ホーム 教室紹介 学会発表・講義(国際学会) 学会発表・講義(国際) 2005年

学会発表・講義(国際) 2005年

  • American Transplant Congress
    2005.05.21-25 Seattle, USA.
  • Watarai Y, Morita K, Fukuzawa N, Takekuma Y, Takada H, Yamazaki K, Sugawara M, Nonomura K.
    Limited sampling strategy for therapeutic drug monitoring of mycophenolic acid under tacrolimus-based immunosuppression after renal transplantation.
  • Ishida M, Miura M, Harada H, Hirano T.
    Latent immunoglobulin A deposition in kidney allografts impacts subsequent graft function.
  • Miura M, Harada H, Iwami D, Taniguchi A, Seki T, Togashi M, Hirano T.
    Prednisone dose limits the improvement of bone mineral density by alendronate and vitamin D.

  • 3rd Congress of the International Pediatric Transplant Association
    2005.08.06-09 Innsbruck, Austria
  • Watarai Y, Morita K, Miura M, Fukuzawa N, Kakizaki H, Obigane K, Nakashima Y, Sasaki S, Nonomura K.
    Pre-emptive living donor renal transplantation -advantage in growth-

  • 20th European Association of Urology Congress
    2005.03.16-19 Istanbul, Turkey.
  • Shinohara N, Suzuki S, Abe T, Murakumo M, Nagamori S, Mitsuhashi K, Harabayashi T, Nonomura K.
    Salvage chemotherapy with paclitaxel, ifosfamide and nedaplatin (PIN regimen) in patients with urothelial cancer who have received prior cisplatin-based therapy.
  • Abe T, Tada M, Shinohara N, Harabayashi T, Maruo S, Sazawa A, Minami K, Maruyama S, Takeda K, Nonomura K.
    The dense infiltration of Epstein-Barr virus-harboring lymphocyte is detected in a large subset of Japanese bladder cancers.

  • 41st American Society of Cancer Oncology annual meeting
    2005.05.13-17 Orlando, USA.
  • Shinohara N, Suzuki S, Harabayashi T, Murakumo M, Mitsuhashi K, Demura T, Nagamori S, Nonomura K
    Combination chemotherapy paclitaxel, ifosfamide and nedaplatin in the treatment for advanced or recurrent urothelial cancer.

  • 100th American Urological Association annual meeting
    2005.05.21-26 San Antonio, USA.
  • Shinohara N, Suzuki S, Abe T, Sazawa A, Harabayashi T, Nonomura K.
    Salvage chemotherapy with paclitaxel, ifosfamide and nedaplatin in patients with urothelial cancer who have received prior cisplatin-based therapy.
  • Minami K, Yanagawa Y, Shinohara N, Harabayashi T, Onoe´ K, Nonomura K.
    IL-4 enhances NKT cell-mediated IFN-gamma production and anti-tumor immunity against murine renal cancer in alpha-galactosylceramide injected mice.
  • Kitta T, Kakizaki H, Furuno T, Moriya K, Tanaka H, Nonomura K, Shiga T, Tamaki N, Sasaki H.
    Brain activation during detrusor overactivity In patients with parkinson disease: A positron emission tomography study.

  • 35th Incontinence Conference Society and International Urogynecological Association
    2005.08.28-09.02 Montreal, Canada.
  • Kitta T, Kakizaki H, Furuno T, Moriya K, Tanaka H, Nonomura K, Shiga T, Tamaki N, Sasaki H.
    Brain activation during detrusor overactivity In patients with parkinson disease: A positron emission tomography study.

  • The 7th meeting of Asia Pasific Association of Pediatric Urologist
    2005.09.28-29 Kyoto Japan.
  • Moriya K, Kakizaki H, Tanaka H,Furuno T, Higashiyama H, Sano H, Kitta T, Nonomura K.
    Long-term cosmetic and sexual outcome of hypospadias surgery: Norm-related study in adolescent.
  • Furuno T, Kakizaki H, Moriya K, Tanaka H, Kitta T,Nonomura K.
    Repair of epispadias: experience of Mitchell technique in 3 cases.
  • Higashiyama H, Moriya K, Mitsui T, Sano H, Tanaka H, Kakizaki H, Nonomura K.
    Long-term outcome of feminizing genitoplasty.
  • Kitta T, Kakizaki H, Moriya K, Furuno T, Tanaka H, Nonomura K.
    Impact of ultrasonography on asymptomatic congenital hydronephrosis.

  • National Conference and Exhibition American Academy of Pediatrics Section on Urology
    2005.10.08-11 Washington DC, USA.
  • Moriya K, Kakizaki H, Tanaka H, Furuno T, Higashiyama H, Sano H, Kitta T, Nonomura K.
    Cosmetic and sexual outcome in adolescent with hypospadias operated in childhood. Norm-related study.
  • Moriya K, Kakizaki H, Tanaka H, Furuno T, Kitta T, Nonomura K.
    Competence of ureterovesical junction improves by bladder management in children with myelodysplasia.